Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EVLO | AZN | AMGN | GILD | BMY |
| Company | Evelo Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0001 | 205.45 | 345.61 | 140.11 | 58.01 |
| High | 0.0001 | 206.73 | 351.33 | 141.17 | 59.04 |
| Low | 0.0001 | 204.27 | 342.35 | 138.47 | 57.67 |
| Latest | 0.0001 | 204.48 | 349.68 | 141.34 | 58.84 |
| Change | unch | +3.67 | +9.68 | +2.54 | +1.17 |
| % Change | unch | +1.83% | +2.85% | +1.83% | +2.03% |
| Volume | 600 | 1,021,403 | 804,696 | 1,372,636 | 4,545,796 |
| 20-Day Average Volume | 4,175 | 1,839,576 | 2,602,947 | 5,914,106 | 13,228,904 |
| Previous Close | 0.0001 | 200.81 | 340.00 | 138.80 | 57.67 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0003 | 192.61 | 353.86 | 140.28 | 59.05 |
| 20-Day Raw Stochastic | 0.00% | 90.96% | 33.67% | 44.06% | 38.87% |
| 20-Day Relative Strength | 44.53 | 60.04 | 46.34 | 49.56 | 49.07 |
| Weighted Alpha | -61.18 | +53.60 | +23.06 | +35.42 | +21.89 |
| Today's Opinion | 100% Sell | 88% Buy | 40% Buy | 56% Buy | 48% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 24% Buy | 40% Buy | 48% Buy |
| Last Month's Opinion | 56% Sell | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 02/04/26 | +3.71% since 03/31/26 | -0.46% since 03/31/26 | +0.94% since 03/31/26 | -3.22% since 03/31/26 |
| Low | 0.0001 on 04/02/26 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 0.0005 on 03/03/26 | 206.73 on 04/08/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | unch since 02/23/26 | +5.31% since 03/06/26 | -5.22% since 03/06/26 | -2.26% since 03/06/26 | -2.65% since 03/06/26 |
| Low | 0.0001 on 04/02/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 0.0005 on 03/03/26 | 206.73 on 04/08/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -80.00% since 12/31/25 | +8.78% since 01/08/26 | +6.10% since 01/08/26 | +16.58% since 01/08/26 | +5.00% since 01/08/26 |
| Low | 0.0001 on 04/02/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 0.0005 on 03/03/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -80.00% since 09/29/25 | +19.78% since 10/08/25 | +18.88% since 10/08/25 | +18.97% since 10/08/25 | +31.78% since 10/08/25 |
| Low | 0.0001 on 04/02/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 0.0005 on 03/03/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2 | 311,437,824 | 183,283,120 | 172,281,616 | 117,746,848 |
| Shares Outstanding, K | 18,840 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -114,530,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -12,360,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.61 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 01/02/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.14 | 15.68 | 17.19 | 9.65 |